Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
| Number | Exp. Date Sort descending | Activity Code(s) | Title |
|---|---|---|---|
| PAR-21-315 | June 21, 2024 | UG3/UH3 | Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) |
| PAR-21-282 | June 21, 2024 | U44 | Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional) |
| PAR-21-349 | June 22, 2024 | R01 | Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required) |
| PAR-21-350 | June 22, 2024 | R01 | Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed) |
| PA-21-268 | July 1, 2024 | 777 | Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) |
| RFA-OD-22-009 | July 2, 2024 | R01 | Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed) |
| RFA-OD-22-007 | July 2, 2024 | R21 | INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) |
| RFA-OD-22-008 | July 2, 2024 | R03 | Small Research Grants for Analysis, Curation, and/or Sharing of Down syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed) |
| RFA-OD-22-010 | July 2, 2024 | R61/R33 | Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required) |
| RFA-AG-25-002 | July 3, 2024 | U54 | Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional) |
| RFA-OD-21-007 | July 4, 2024 | R21 | INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed) |
| NOT-OD-24-026 | July 16, 2024 | R21 | Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21) |
| NOT-NS-22-003 | July 17, 2024 | R01,R21 | Notice of Special Interest: Advancing Research in Gastrointestinal Dysfunction in People with Neurodevelopmental Disorders |
| RFA-HD-25-009 | July 25, 2024 | R21 | Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed) |
| RFA-HD-25-001 | July 31, 2024 | P50 | Medical Rehabilitation Research Resource (P50 Clinical Trial Optional) |
| RFA-AI-24-018 | July 31, 2024 | R01 | Interaction between ARVs and Hormones in HIV and Coinfections (R01 Clinical Trial Optional) |
| RFA-HD-25-004 | July 31, 2024 | U19 | Optimizing Health of Children and Adolescents with Perinatal HIV Exposure (U19 Clinical Trial Optional) |
| PAR-24-206 | August 14, 2024 | U54 | Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) |
| RFA-MH-25-186 | August 14, 2024 | R21 | Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional) |
| RFA-MH-25-185 | August 14, 2024 | R01 | Advancing HIV service delivery through pharmacies and pharmacists (R01 Clinical Trial Optional) |
BACK TO TOP